...
首页> 外文期刊>Advances in Experimental Medicine and Biology >APC and Its Modifiers in Colon Cancer
【24h】

APC and Its Modifiers in Colon Cancer

机译:APC及其调节剂在结肠癌中

获取原文
获取原文并翻译 | 示例
           

摘要

Colon cancer closely follows the paradigm of a single "gatekeeper gene." Mutations inactivating the APC (adenomatous polyposis colt) gene are found in -80% of all human colon tumors and heterozygosity for such mutations produces an autosomal dominant colon cancer predisposition in humans and in murine models. However, this tight association between a single genotype and phenotype belies a complex association of genetic and epigenetic factors that together generate the broad phenotypic spectrum of both familial and sporadic colon cancers. In this Chapter, we give a general overview of the structure, function and outstanding issues concerning the role of Apc in human and experimental colon cancer. The availability of increasingly close models for human colon cancer in genetically tractable animal species enables the discovery and eventual molecular identification of genetic modifiers of the Apc-mutant phenotypes, connecting the central role of Apc in colon carcinogenesis to the myriad factors that ultimately determine the course of the disease.
机译:结肠癌紧密遵循单一“门卫基因”的范式。灭活APC(腺瘤性息肉菌塞COLT)基因的突变在-80%的所有人结肠肿瘤中发现,这种突变的杂合子在人类和小鼠模型中产生常染色体显性结肠癌探测。然而,这种单一基因型和表型之间的紧张关联伴有遗传和表观遗传因素的复杂关联,其共同产生家族和散发性结肠癌的广泛表型谱。在本章中,我们概述了关于APC在人类和实验性结肠癌中的作用的结构,功能和突出问题的一般性概述。在转基因动物物种中越来越多的人结肠癌模型的可用性能够发现和最终分子鉴定APC-突变表型的遗传调节剂,将APC在结肠癌中的核心作用连接到最终确定课程的无数因素疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号